A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan

BACKGROUND: Intra-articular hyaluronan (HA) injection provides symptomatic benefit in the treatment of osteoarthritis (OA). Previously we found superior beneficial effects in a large animal OA model of a hexadecylamide derivative compared with unmodified HA of the same initial molecular weight. The...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smith, Margaret M, Russell, Amy K, Schiavinato, Antonella, Little, Christopher B
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3727958/
https://ncbi.nlm.nih.gov/pubmed/23889808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-9255-10-26
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items